Antiemetic research: future directions. (Q39818791)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21063733%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

title

Antiemetic research: future directions (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21063733%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21063733%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Ian Olver

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21063733%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Matti Aapro

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21063733%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Jørn Herrstedt

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21063733%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Steven Grunberg

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21063733%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Garry Morrow

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21063733%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

publication date

10 November 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21063733%20AND%20SRC:MED&resulttype=core&format=json

Supportive Care in Cancer

16 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21063733%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

volume

19 Suppl 1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21063733%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

page(s)

S49-55

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21063733%20AND%20SRC:MED&resulttype=core&format=json

Double-blind, randomised, controlled study of the efficacy and tolerability of palonosetron plus dexamethasone for 1 day with or without dexamethasone on days 2 and 3 in the prevention of nausea and vomiting induced by moderately emetogenic chemothe

16 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1036-1

Delayed nausea and vomiting continue to reduce patients' quality of life after highly and moderately emetogenic chemotherapy despite antiemetic treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1036-1

A review of patient self-report tools for chemotherapy-induced nausea and vomiting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1036-1

What is a clinically meaningful change on the Functional Assessment of Cancer Therapy-Lung (FACT-L) Questionnaire? Results from Eastern Cooperative Oncology Group (ECOG) Study 5592.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1036-1

Receptor mechanism and antiemetic activity of structurally-diverse cannabinoids against radiation-induced emesis in the least shrew

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1036-1

Patient perceptions of the side-effects of chemotherapy: the influence of 5HT3 antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1036-1

Ondansetron compared with high-dose metoclopramide in prophylaxis of acute and delayed cisplatin-induced nausea and vomiting. A multicenter, randomized, double-blind, crossover study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1036-1

Implementing evidence based antiemetic guidelines in the oncology setting: results of a 4-month prospective intervention study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1036-1

Aprepitant in adolescent patients for prevention of chemotherapy-induced nausea and vomiting: a randomized, double-blind, placebo-controlled study of efficacy and tolerability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1036-1

Randomized, placebo-controlled, pilot study evaluating aprepitant single dose plus palonosetron and dexamethasone for the prevention of acute and delayed chemotherapy-induced nausea and vomiting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1036-1

Evaluation of risk factors predictive of nausea and vomiting with current standard-of-care antiemetic treatment: analysis of two phase III trials of aprepitant in patients receiving cisplatin-based chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1036-1

Prevention of chemotherapy-induced nausea and vomiting in elderly cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1036-1

Potent, brain-penetrant, hydroisoindoline-based human neurokinin-1 receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1036-1

Structure and receptor binding of PYY analogs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1036-1

Omission of day 2 of antiemetic medications is a cost saving strategy for improving chemotherapy-induced nausea and vomiting control: results of a randomized phase III trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1036-1

Measuring chemotherapy-induced nausea and emesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1036-1

A prospective observational study of chemotherapy-related nausea and vomiting in routine practice in a UK cancer centre

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1036-1

Understanding the concept of chemotherapy-related nausea: the patient experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1036-1

A phase II trial of olanzapine, dexamethasone, and palonosetron for the prevention of chemotherapy-induced nausea and vomiting: a Hoosier oncology group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1036-1

Quantitative analysis of NK1 receptor in the human brain using PET with 18F-FE-SPA-RQ.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1036-1

Relationships between patients' pre-treatment expectations of toxicities and post chemotherapy experiences

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1036-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1036-1

Acupressure bands are effective in reducing radiation therapy-related nausea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1036-1

Insight in the prediction of chemotherapy-induced nausea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1036-1

Modulation of emesis by fentanyl and opioid receptor antagonists in Suncus murinus (house musk shrew).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1036-1

Management of cyclophosphamide-induced emesis over repeat courses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1036-1

Clinical research of Olanzapine for prevention of chemotherapy-induced nausea and vomiting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1036-1

Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1036-1

Variations in the 5-hydroxytryptamine type 3B receptor gene as predictors of the efficacy of antiemetic treatment in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1036-1

Delta9-tetrahydrocannabinol selectively acts on CB1 receptors in specific regions of dorsal vagal complex to inhibit emesis in ferrets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1036-1

Side effects associated with the use of dexamethasone for prophylaxis of delayed emesis after moderately emetogenic chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1036-1

A review of nabilone in the treatment of chemotherapy-induced nausea and vomiting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1036-1

Reduced ghrelin secretion in the hypothalamus of rats due to cisplatin-induced anorexia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1036-1